Clopivas 300mg Tablet
Marketer
Cipla Ltd
Salt Composition
Clopidogrel (300mg)
Overview Clopivas 300mg Tablet
Trombopro 300mg tablets are antiplatelet agents, preventing the formation of dangerous blood clots within blood vessels. This reduces the risk of stroke and heart attack, making it a common heart-protective medication. Trombopro 300mg is prescribed for individuals at heightened risk of cardiovascular events, including those with peripheral arterial disease (circulatory issues from narrowed arteries), recent stroke or myocardial infarction, arrhythmias, and post-stent placement. It's also used alongside other medications to manage heart attacks and unstable angina. This medication can be taken with or without food, consistently at the same time daily. Continued use is crucial, even feeling well; discontinuation increases the risk of stroke or heart attack. The most prevalent side effect is increased bleeding, manifesting as bruising, epistaxis, hematuria, melena (dark stools), or heavier menstrual bleeding. Wounds may bleed longer than usual. While typically mild and self-resolving, persistent or concerning bleeding warrants immediate medical attention. This medication is contraindicated in individuals with active internal bleeding (e.g., stomach ulcer, intracranial hemorrhage). Inform your physician of any clotting disorders or recent significant trauma or surgery before commencing treatment. Temporary cessation may be necessary before scheduled surgery or dental procedures.
Primary Ingredients of Clopivas 300mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Clopivas 300mg Tablet
Reducing the risk of cardiovascular events
Major Benefits of Clopivas 300mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 300mg Clopivas Tablet whole; avoid chewing, crushing, or breaking it. While you can take it with or without food, consistent timing is recommended.
Common Side effects of Clopivas 300mg Tablet:
- Abdominal pain
- Bruise
- Diarrhea
- Hematoma
- Nosebleeds
- Gastrointestinal bleeding
- Dyspepsia
How to use Clopivas 300mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 300mg Clopivas Tablet whole; avoid chewing, crushing, or breaking it. While Clopivas 300mg Tablets can be taken with or without food, consistent timing is recommended.
How Clopivas 300mg Tablet works:
Ticagrelor 300mg tablets are used to inhibit platelet aggregation. This action reduces the risk of dangerous blood clots, thus lowering the likelihood of stroke or myocardial infarction.
SAFETY ADVICE
AlcoholCAUTION
Use caution when combining Clopivas 300mg Tablet and alcohol. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
Using Clopivas 300mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against potential hazards prior to prescribing. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
Lactation and the 300mg Clopivas tablet appear compatible. Available human data indicates minimal infant risk associated with its use during breastfeeding.
DrivingSAFE
Driving ability is typically unaffected by Clopivas 300mg tablets.
KidneySAFE IF PRESCRIBED
Renal impairment does not necessitate dosage modification for Clopivas 300mg tablets, which are considered safe for use in such patients.
LiverSAFE IF PRESCRIBED
Patients with liver disease can safely use Clopivas 300mg tablets without requiring any alteration to the prescribed dosage.
What if you forget to take Clopivas 300mg Tablet :
Should you forget a Clopivas 300mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Clopivas 300mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Amino acid alpha esters |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Actions | ADP receptor antagonists (P2Y12 inhibitors) |





